acromegaly

Oral Injection alternative for Acromegaly

Adults who need medical maintenance treatment of the growth hormone disorder acromegaly respond well to an investigational oral form of the drug octreotide, investigators of the Chiasma OPTIMAL study reported. Results of the phase 3 randomized controlled clinical trial were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published […]

Pegvisomant (Somavert) for acromegaly treatment

United States of America – The Food and Drug Administration (FDA) has approved pegvisomant (SomavertĀ®) for the treatment of acromegaly, a potentially life threatening disease triggered by an excess of growth hormone. Pegvisomant, the first in a new class of drugs called growth hormone receptor antagonists, is approved for patients who have had an inadequate […]

In Octreotide Researchers offer hope for an oral, noninjectable treatment of acromegaly

  Adults who need medical maintenance treatment of the growth hormone disorder acromegaly respond well to an investigational oral form of the drug octreotide, investigators of the Chiasma OPTIMAL study reported. Results of the phase 3 randomized controlled clinical trial were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be […]

Scroll to top